Vericel Corp (VCEL) SEC Filings & Financial Intelligence
Vericel Corp (VCEL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VCEL
CIK: 887359
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: MI
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKenneth Richardson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144/A | 2026-11-06 | — | 144/A Filing | 0001959173-26-007838 | View SEC Doc Filr Page |
| 144 | 2026-11-06 | — | 144 Filing | 0001959173-26-007835 | View SEC Doc Filr Page |
| 4 | 2026-11-06 | 2026-11-05 | FORM 4 | 0001140361-26-042463 | View SEC Doc Filr Page |
| 4 | 2026-11-06 | 2026-11-05 | FORM 4 | 0001140361-26-042464 | View SEC Doc Filr Page |
| 4 | 2026-11-06 | 2026-11-04 | FORM 4 | 0001140361-26-042462 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001959173-26-007800 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001959173-26-007798 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001959173-26-007797 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001959173-26-007788 | View SEC Doc Filr Page |
| 10-Q | 2026-11-05 | 2026-09-30 | 10-Q | 0001628280-26-070657 | View SEC Doc Filr Page |
| 8-K | 2026-11-05 | 2026-11-05 | 8-K | 0001628280-26-070622 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001959173-26-007757 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001140361-26-033143 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088745 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001959173-26-005916 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001140361-26-031417 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001959173-26-005511 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-30 | FORM 4 | 0001140361-26-030487 | View SEC Doc Filr Page |
| 144 | 2026-07-30 | — | 144 Filing | 0001959173-26-005454 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001628280-26-050836 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001628280-26-050815 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0001140361-26-026932 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0001140361-26-026931 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0001140361-26-026930 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0001140361-26-026929 | View SEC Doc Filr Page |